Cinaciguat
CAS No. 329773-35-5
Cinaciguat ( —— )
产品货号. M14089 CAS No. 329773-35-5
Cinaciguat (BAY 58-2667) 是临床开发中第一种新型可溶性鸟苷酸环化酶 (sGC) 激活剂,用于治疗急性失代偿性心力衰竭。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥610 | 有现货 |
|
| 10MG | ¥941 | 有现货 |
|
| 25MG | ¥1655 | 有现货 |
|
| 50MG | ¥2492 | 有现货 |
|
| 100MG | ¥3384 | 有现货 |
|
| 200MG | ¥4617 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥758 | 有现货 |
|
生物学信息
-
产品名称Cinaciguat
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Cinaciguat (BAY 58-2667) 是临床开发中第一种新型可溶性鸟苷酸环化酶 (sGC) 激活剂,用于治疗急性失代偿性心力衰竭。
-
产品描述Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in clinical development for acute decompensated heart failure.(In Vitro):Cinaciguat (10 μM) significantly enhances intracellular cGMP generation. Cinaciguat does not dose-dependent effects on cell contraction and calcium transients.(In Vivo):Cinaciguat (10 mg/kg/day, p.o.) treatment in diabetic rats does not influence blood glucose levels, but leads to attenuated water intake. Cinaciguat treatment alleviates diabetes mellitus related oxidative stress, protects against DM related alteration of the NO-sGC-cGMP-PKG signalling, and alleviates DM related myocardium hypertrophy and apoptosis. Cinaciguat (1-10-100 nM) induces concentration-dependent relaxations in strips from both WT and apo-sGC mice, but does not have any effect on phasic activity induced by PGF2α in WT or apo-sGC strips.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体sGC
-
研究领域Cardiovascular Disease
-
适应症——
化学信息
-
CAS Number329773-35-5
-
分子量565.7
-
分子式C36H39NO5
-
纯度>98% (HPLC)
-
溶解度DMSO: 10 mM
-
SMILESOC(=O)CCCCN(CCC1=CC=CC=C1OCC1=CC=C(CCC2=CC=CC=C2)C=C1)CC1=CC=C(C=C1)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
Kaempferol 3,7-di-O-...
Kaempferol-3,7-di-O-β-glucoside (Kaempferol 3,7-diglucoside) is a flavonol from Morettia philaena, It can inhibit α-amylase, α-glucosidase and Acetylcholinesterase. Kaempferol-3, 7-di-o-β-Glucoside has neuroprotective activity and can slow down differentiated neuronal cells SH-SY5Y from Amyloid β peptide-induced damage.
-
CALP1
Cell-permeable calmodulin (CaM) agonist that binds to the EF-hand/Ca2+-binding site; produces CaM-dependent activation of phosphodiesterase. Also binds to cytoplasmic sites on other Ca2+ channels, including NMDA and HIV-1 gp120-activated channels, inhibiting Ca2+-mediated cytotoxicity and apoptosis (IC50 = 52 μM). Shown to protect pancreatic acinar cells from gossypol induced necrosis. Inhibits VLA-5-mediated adhesion of mast cells to fibronectin in vitro and attenuates inflammatory cell influx in guinea pig lung in vivo.
-
3-O-Feruloylquinic a...
3-O-Feruloylquinic acid is a protease inhibitor, it exerts moderate inhibitory effect against AIV (H5N1) in vitro.
021-51111890
购物车()
sales@molnova.cn

